Clinical Trials Browser

Carcinoma, Adenoid Cystic × enfortumab vedotin × 90 days × Clear all

NCT06891560 2026-03-20

A Study of Enfortumab Vedotin in People With Adenoid Cystic Carcinoma

Phase 2 Recruiting

Carcinoma, Adenoid Cystic